Atlas Trials

Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.

Clinical trial NCT03674359 · UNKNOWN

Trial details

NCT number
NCT03674359
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
Infection, Fungal
Start date
2018-12-12
Primary completion
2021-09-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.